Serum IL-35 levels tied to bone loss with rheumatoid arthritis

Serum interleukin (IL)-35 levels are associated with bone loss and may represent a novel therapeutic target for postmenopausal women with rheumatoid arthritis (RA), according to a study published onli

Updated on: June 06,2024

Serum IL-35 levels tied to bone loss with rheumatoid arthritis

Serum interleukin (IL)-35 levels are associated with bone loss and may represent a novel therapeutic target for postmenopausal women with rheumatoid arthritis (RA), according to a study published onli

Updated on:June 06,2024

A metabolic enzyme as a potential new target for cancer immune therapies

by German Cancer Research CenterCredit: Unsplash/CC0 Public DomainThe metabolic enzyme IL4I1 (Interleukin-4-Induced-1) promotes the spread of tumor cells and suppresses the immune system. This wa

Updated on: May 07,2024

A metabolic enzyme as a potential new target for cancer immune therapies

by German Cancer Research CenterCredit: Unsplash/CC0 Public DomainThe metabolic enzyme IL4I1 (Interleukin-4-Induced-1) promotes the spread of tumor cells and suppresses the immune system. This wa

Updated on:May 07,2024

COVID-19 vaccines produce antibody response in the nasal mucosa

by University of North Carolina Health CarePre-immunity and post-immunity SARS-CoV-2 virus-specific IgG and IgA antibody concentrations in NELF and serum. Antibody concentrations were reported as

Updated on: April 13,2024

COVID-19 vaccines produce antibody response in the nasal mucosa

by University of North Carolina Health CarePre-immunity and post-immunity SARS-CoV-2 virus-specific IgG and IgA antibody concentrations in NELF and serum. Antibody concentrations were reported as

Updated on:April 13,2024

T-cell dysfunction increases cancer risk in obese populations, researchers say

bySaint Louis UniversityCD8+T cell dysfunction in the obese tumor microenvironment. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-47359-5Researchers at Saint Loui

Updated on: November 24,2024

T-cell dysfunction increases cancer risk in obese populations, researchers say

bySaint Louis UniversityCD8+T cell dysfunction in the obese tumor microenvironment. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-47359-5Researchers at Saint Loui

Updated on:November 24,2024

Guidance for coronary patients with ASA/NSAID sensitivity

(HealthDay)—In patients with stable chronic ischemic heart disease (CIHD) and histories of nonsevere hypersensitivity reactions to acetylsalicylic acid (ASA)/nonsteroidal anti-inflammatory drugs (NSAI

Updated on: April 08,2024

Guidance for coronary patients with ASA/NSAID sensitivity

(HealthDay)—In patients with stable chronic ischemic heart disease (CIHD) and histories of nonsevere hypersensitivity reactions to acetylsalicylic acid (ASA)/nonsteroidal anti-inflammatory drugs (NSAI

Updated on:April 08,2024

New prediction model could help inform patients of their risks of having shoulder replacement surgery

byUniversity of OxfordCredit: Pixabay/CC0 Public DomainA new model to predict the risk of serious complications after shoulder replacement surgery has been developed in a collaboration between r

Updated on: August 08,2024

New prediction model could help inform patients of their risks of having shoulder replacement surgery

byUniversity of OxfordCredit: Pixabay/CC0 Public DomainA new model to predict the risk of serious complications after shoulder replacement surgery has been developed in a collaboration between r

Updated on:August 08,2024

The role of T-cells in SARS-CoV-2 virus defense

by Universitaet TübingenA colorized scanning electron micrograph of the SARS-CoV-2 virus. Credit: NIAIDOur immune system can efficiently fend off viral diseases. T-cells can directly destroy viru

Updated on: May 05,2024

The role of T-cells in SARS-CoV-2 virus defense

by Universitaet TübingenA colorized scanning electron micrograph of the SARS-CoV-2 virus. Credit: NIAIDOur immune system can efficiently fend off viral diseases. T-cells can directly destroy viru

Updated on:May 05,2024

COVID-19 infection rates low in people with rheumatic diseases, most report mild illness

by American College of RheumatologyCredit: CC0 Public DomainA new study shows that the COVID-19 infection incidence has been low in people with rheumatic diseases, and most of those infected expe

Updated on: May 23,2024

COVID-19 infection rates low in people with rheumatic diseases, most report mild illness

by American College of RheumatologyCredit: CC0 Public DomainA new study shows that the COVID-19 infection incidence has been low in people with rheumatic diseases, and most of those infected expe

Updated on:May 23,2024

Bioluminescence technology reveals role of protein in immune response modulation

byUniversity of Western AustraliaCredit: Pixabay/CC0 Public DomainCutting-edge bioluminescence technology pioneered at The University of Western Australia has been used to uncover a potential ga

Updated on: March 27,2024

Bioluminescence technology reveals role of protein in immune response modulation

byUniversity of Western AustraliaCredit: Pixabay/CC0 Public DomainCutting-edge bioluminescence technology pioneered at The University of Western Australia has been used to uncover a potential ga

Updated on:March 27,2024

Physical activity reduces cardiovascular risk in rheumatic patients

by FAPESPPeople with diseases such as rheumatoid arthritis and lupus are more likely to have heart attacks, angina, and strokes. A review of the scientific literature on the subject shows that re

Updated on: June 26,2024

Physical activity reduces cardiovascular risk in rheumatic patients

by FAPESPPeople with diseases such as rheumatoid arthritis and lupus are more likely to have heart attacks, angina, and strokes. A review of the scientific literature on the subject shows that re

Updated on:June 26,2024

Pretreatment with TNF inhibitors may improve outcomes of combination cancer immunotherapy

by Universidad de NavarraStudy proposes a new therapeutic approach against cancer that dissociates efficacy and toxicity in the use of combined immunotherapy in animal models. This clinical strat

Updated on: May 08,2024

Pretreatment with TNF inhibitors may improve outcomes of combination cancer immunotherapy

by Universidad de NavarraStudy proposes a new therapeutic approach against cancer that dissociates efficacy and toxicity in the use of combined immunotherapy in animal models. This clinical strat

Updated on:May 08,2024

Patient-driven discovery reveals potential target for autoimmune diseases

by Isabella Backman,Yale UniversityModel summarizing the function of PI3Kγ in antibody responses. Credit:Nature Immunology(2024). DOI: 10.1038/s41590-024-01890-1A medical mystery ser

Updated on: July 17,2024

Patient-driven discovery reveals potential target for autoimmune diseases

by Isabella Backman,Yale UniversityModel summarizing the function of PI3Kγ in antibody responses. Credit:Nature Immunology(2024). DOI: 10.1038/s41590-024-01890-1A medical mystery ser

Updated on:July 17,2024